Trial Profile
Prospective, Case Control Study Investigating the Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine vs 23-Valent Polysaccharide Vaccine in HIV Infected Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jan 2015
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine
- Indications Pneumococcal infections
- Focus Adverse reactions; Pharmacodynamics
- 23 Jan 2015 New trial record